I want to get continuous structured data on emerging medical risk indicators, mortality trends, and competitive underwriting guidelines from public health databases, medical research publications, and competitor insurance provider documentation.
A shared demo template. Read-only preview of what would be monitored in a real pilot.
Click to explore each section
This is a real demo!
Click to explore each section.
Pilot Configuration
Goal
I want to get continuous structured data on emergi...
Access continuous insights on medical risks and mortality trends — automated intelligence for smarter underwriting decisions
12 website or app sources
The Jsonify AI will open these automatically to explore and find your information
10
data columns
12
dashboard widgets
3
integrations
1
notification
Recommended
Pilot Phase (Scoped Evaluation)
Up to 12 weeks
€3,000
/ month
Typical scope: multi-country, weekly updates, multiple categories
- Real data from real sources
- Live dashboards or export feeds
- Validate scope, refresh cadence, quality
- Fixed price, no ongoing commitment
Most teams start here to validate fit before expanding.
Now, schedule a short call below to confirm scope and start the pilot, or build something new.
or email us at paul@jsonify.co
Data sources are the websites and apps where information will be collected from. These can be changed or expanded at any time. This is turned into data rows.
Sample data preview. This is synthetic test data generated to illustrate the structure. Real data from your sources will be populated during the pilot. This data powers the dashboard widgets.
| id | Source | Indicator | Value | 95% CI | Geography | Age Group | Trend | Last Updated | Notes | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
|
All-cause mortality rate (per 100k) |
|
|
United States (national) | All ages | Upward (3.2% vs prior year) | Feb 2, 2026 | Provisional NVSS weekly estimate; increases concentrated in heart disease and unintentional injury codes ... show all |
||
| 2 |
|
Long COVID prevalence | 8.9% |
|
United States (sample survey) | 18+ | Stable | Feb 3, 2026 | NIH RECOVER interim analysis; self-reported symptoms >12 weeks post-infection | ||
| 3 |
|
Influenza A(H3N2) hospitalization rate (per 100k) |
|
|
Global (selected high-income countries) | 65+ | Rising | Feb 1, 2026 | FluNet sentinel surveillance; early-season surge in northern hemisphere | ||
| 4 |
|
Relative risk: dementia after severe COVID |
|
|
Multi-country cohort meta-analysis | 50+ | Elevated risk (compared to uninfected) | Feb 2, 2026 | Peer-reviewed cohort meta-analysis published online; adjusted for comorbidities | ||
| 5 |
|
Opioid overdose ED visit rate (per 100k) |
|
|
US - state median | 25–44 | Decreasing (−4.5% 4-week) | Feb 3, 2026 | Syndromic surveillance; some states still report increases | ||
| 6 |
|
30-day post-discharge readmission rate (%) | 12.1% |
|
United States - Medicare FFS | 65+ | Flat | Feb 2, 2026 | CMS Hospital Compare 30-day metric; downward improvements in CHF observed | ||
| 7 |
|
Underwriting BMI cutoff for preferred rate | <27.5 kg/m² | N/A | California | 18–65 | No change | Feb 3, 2026 | Regulatory bulletin summarizing insurer guideline updates; standard limits retained | ||
| 8 |
|
Physician workforce vacancy rate (%) | 6.8% |
|
United States - rural counties | All ages (provider metric) | Worsening | Feb 1, 2026 | AAMC state workforce survey; shortages greatest in psychiatry and primary care | ||
| 9 |
|
Avg. term life application decline rate (%) | 9.3% |
|
US market aggregated | 20–55 | Upward | Feb 3, 2026 | Aggregate of carrier underwriting outcomes; increases tied to cardiometabolic indicators | ||
| 10 |
|
Uninsured rate (%) | 8.6% |
|
United States | 18–64 | Declining | Feb 2, 2026 | KFF analysis of CPS supplement; Medicaid expansion states show larger declines | ||
| 11 |
|
Excess deaths attributable to heat (per 100k) |
|
|
United States - summer months | 65+ | Increasing | Feb 1, 2026 | Time-series analysis linking temperature anomalies to mortality; urban heat islands major driver | ||
| 12 |
|
Relative mortality risk - uninsured vs insured |
|
|
United States (panel study) | 25–64 | Persistent disparity | Feb 3, 2026 | Longitudinal study using NHIS-NDI linkage; controls for SES and comorbidities | ||
| 13 |
|
COVID-19 vaccine effectiveness vs hospitalization (%) | 72 | 68–76 | United States - adults | 18+ | Slight decline vs prior season | Feb 4, 2026 | VE estimated from IVY network; waning observed in older adults | ||
| 14 |
|
Newly reported adverse event: myocarditis post-mRNA (%) | 0.006% |
|
US passive surveillance | 12–29 males | Stable low incidence | Feb 2, 2026 | VAERS/active surveillance synthesis; clinical course typically mild | ||
| 15 |
|
Measles incidence (per 100k) |
|
|
Global - LMIC focal areas | <5 | Localized outbreaks | Feb 1, 2026 | Supplemental immunization activity reported in three countries; coverage gaps cited | ||
| 16 |
|
Hazard ratio: cancer mortality with diabetes |
|
|
Systematic review - multi-country | 40+ | ElevatedRisk | Feb 3, 2026 | Meta-analysis of cohort studies; heterogeneity by cancer type | ||
| 17 |
|
COVID-19 wastewater viral load (copies/ml) |
|
|
US metro sentinel | All ages (community) | Rising (2-week) | Feb 4, 2026 | Wastewater Surveillance System; correlates with clinical case uptick | ||
| 18 |
|
Average monthly Medicare Advantage premium ($) | $26.40 | $25.80–$26.95 | United States - national average | 65+ | Slight increase | Feb 2, 2026 | MA rate filings aggregated; plan benefit enhancements observed | ||
| 19 |
|
Preferred smoker surcharge (%) | 35 | N/A | California | 18–65 | Stable | Feb 3, 2026 | Consumer rate guidance; reflects actuarial loading for tobacco use | ||
| 20 |
|
Medical school enrollment growth (%) |
|
|
United States | All ages (applicants) | Gradual increase | Feb 1, 2026 | AAMC AMCAS cycle preliminary data; growth concentrated in osteopathic programs | ||
| 21 |
|
Avg. age at underwriting decline for cardiovascular risk | 54.7 years |
|
US carriers aggregated | 50–65 | Lowering threshold | Feb 3, 2026 | Underwriting policy scan; some carriers tightening on lipids/BP readings | ||
| 22 |
|
Medicaid enrollment change (%) |
|
|
United States - year-over-year | All ages | Upward | Feb 2, 2026 | Post-reform enrollment shifts; states with expanded eligibility show larger gains | ||
| 23 |
|
30-day mortality after hip fracture (%) |
|
|
US hospital registry analysis | 75+ | Stable to slight decline | Feb 1, 2026 | Quality improvement initiatives linked to modest mortality reduction | ||
| 24 |
|
Excess mortality associated with economic downturn | +2.6 per 100k |
|
US counties (economic shock study) | 25–64 | Associated increase | Feb 3, 2026 | Difference-in-differences design; largest effects in opioid-affected counties | ||
| 25 |
|
Pneumococcal vaccination coverage (%) |
|
|
United States - adults 65+ | 65+ | Slow increase | Feb 4, 2026 | NIS-Adult provisional estimates; racial disparities persist | ||
| 26 |
|
New biomarker: circulating mtDNA associated with mortality HR |
|
|
Cohort study (US & Europe) | 50+ | Proposed risk marker | Feb 2, 2026 | Biomarker study in preprint; needs external validation | ||
| 27 |
|
Antimicrobial resistance: carbapenem-resistant Enterobacterales prevalence (%) |
|
|
Global hospital surveillance | All ages | Gradual increase | Feb 1, 2026 | GLASS network summary; highest in APAC region | ||
| 28 |
|
Risk ratio: severe COVID-19 with obesity (BMI≥30) |
|
|
Meta-analysis - adult cohorts | 18+ | Consistent elevated risk | Feb 3, 2026 | Dose-response noted with higher BMI categories | ||
| Looking for more? Great news − this is just a small sample. Jsonify production workflows process anywhere from tens of thousands to millions of real data rows per run! | |||||||||||
From
–
To
Filters
Loading filters...
Loading filters...
Current Emerging Medical Risk Indicators
2,750
total emerging risk indicators
8%
Underwriting Guidelines by Competitor
Trends in Underwriting Changes Over Time
Mortality Trends Over Time
Cumulative Mortality Trends
Proportion of Risk Data from Public Health vs. Competitors
Distribution of Risk Indicators by Source
Detailed Risk Indicators and Sources
| Risk Indicator | Source | Mortality Rate (%) | Emerging Trend | Date of Publication |
|---|---|---|---|---|
| Cardiovascular Disease |
|
|
Rising | 2026-01-15 |
| Chronic Respiratory Diseases |
|
|
Stable | 2026-01-10 |
| Diabetes |
|
|
Rising | 2026-01-20 |
| Obesity |
|
|
Increasing | 2026-01-25 |
| Mental Health Disorders |
|
|
Concerning | 2026-01-30 |
| Cancer |
|
|
Stable | 2026-01-12 |
| HIV/AIDS |
|
|
Decreasing | 2026-01-18 |
| Kidney Disease |
|
|
Increasing | 2026-01-28 |
Key Observations on Emerging Risks
Emerging medical risks related to respiratory illnesses have increased by 15% over the past year, as reported by the CDC.
Recent studies indicate a rising trend in mortality due to heart disease, with a 10% increase noted in 2025 according to NIH data.
Insurance providers are adjusting their underwriting guidelines in response to new data, particularly concerning mental health assessments.
A comparative analysis shows that 25% of competitors have updated their mortality risk models in the last six months, highlighting the urgent need for proactive measures.
Data from WHO indicates a concerning uptick in antibiotic resistance, which may require shifts in policy and insurance coverage strategies.
Top 10 Emerging Risk Indicators
Total Research Publications Reviewed
2,150
total research publications reviewed
18%
Recent Competitor Underwriting Guidelines
| Source | Guideline Type | Target Indicator | Effective Date |
|---|---|---|---|
|
|
COVID-19 Underwriting | Long COVID Risk Assessment | 2026-01-15 |
|
|
Cardiovascular Guidelines | Hypertension Management | 2026-01-20 |
|
|
Infectious Disease Guidelines | Vaccine Update for Adults | 2026-01-25 |
|
|
Cancer Risk Guidelines | Breast Cancer Screening | 2026-01-28 |
|
|
Chronic Disease Guidelines | Diabetes Monitoring Protocol | 2026-01-30 |
|
|
Mental Health Underwriting | Depression Screening Standards | 2026-01-10 |
Structured data feeds are included — we're happy to help with API integration and automation.
JSON
Loading...
CSV
Loading...
Looking for more? Great news − this is just a small sample. Typically, our commercial customers process tens of thousands to millions of data points per task!
Radar continuously monitors your selected web sources and alerts you the moment something changes.
+7
Recent change
New Risk Indicator Detected
1h ago
Emerging Respiratory Illness identified in recent CDC data
Recent change
Mortality Trend Updated
5m ago
Heart Disease Mortality showing significant increase
Recent change
Underwriting Guidelines Change
3h ago
Life Insurance Policies new criteria published by competitors
Recent change
New Competitor Insurance Plan
Yesterday
Comprehensive Health Plan launched by XYZ Insurance
Recent change
Data Availability Change
5m ago
COVID-19 Vaccine Data updated data set from healthdata.gov
Data connections determine where the collected data will be delivered. You can add, remove, or change connections at any time.
Scroll down to see more